QUOTE AND NEWS
Benzinga  May 18  Comment 
Novogen Limited (NASDAQ: NVGN), announced today that company CEO, Dr Graham Kelly, will be a presenting company at Asia Biotech Invest 2015 May 20-21. The Novogen presentation is at 10.00 am May 20 at the Sheraton Hotel and Towers, Hong...
Benzinga  May 14  Comment 
US-Australian drug discovery company, Novogen (NASDAQ: NVGN), today announced that it has confirmed that drug candidate, Anisina, is an effective monotherapy against human melanoma in an animal model. The Company announced recently that Anisina...
Benzinga  May 8  Comment 
Novogen Limited (ADR) (NASDAQ: NVGN) gained 16.82 percent to $7.50 in pre-market trading. According to a Thursday's press release, Australian Studies confirmed that TRXE-009 kills resistant paediatric brain cancer cells. XOMA Corp (NASDAQ:...
The Australian  May 8  Comment 
Drug development company Novogen has again seen its stock soar after announcing a successful study into a new cancer-fighting drug.
Benzinga  Apr 27  Comment 
Graham Kelly, Novogen CEO and Executive Chairman, said, "This rights issue, in conjunction with the recent Placement, is intended to give the Company 2 years of funding to underpin its strong growth strategy." "A successful capital-raising at...
Benzinga  Apr 22  Comment 
US-Australian drug discovery company, Novogen (NASDAQ: NVGN), today announced that its subsidiary joint venture company with Yale University, CanTx, Inc, has today received notification from the U.S. Food and Drug Administration (FDA) that its...
TheStreet.com  Apr 21  Comment 
NEW YORK (TheStreet) -- Shares of Novogen  fell 16.79% to $7.68 in late morning trading Monday after the Australian and U.S. biotechnology company announced it had conducted a private placement and offered rights to shareholders. The company...
The Australian  Apr 21  Comment 
Novogen is tapping investors for $30.5m as it prepares for growth fuelled by development of its cancer-fighting drugs.
TheStreet.com  Apr 17  Comment 
NEW YORK (TheStreet) -- Shares of Novogen  rose 9.06% to $7.57 in afternoon trading Friday after the company announced it had signed a Memorandum of Understanding with the Feinstein Institute for Medical Research of New York to collaborate on...
TheStreet.com  Apr 9  Comment 
NEW YORK (TheStreet) -- Novagen shares spiked 24.72% to $5.62 in trading on Thursday after the Australia-based biotechnology company revealed that studies of its experimental drug, Anisina, showed signs of what could be a breakthrough in...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki